Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The Second Affiliated Hospital of Hainan Medical University
Nanfang Hospital, Southern Medical University
National Taiwan University Hospital
Beijing Tiantan Hospital
Nationwide Children's Hospital
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tianjin Medical University Cancer Institute and Hospital
Mayo Clinic
Tianjin Medical University Cancer Institute and Hospital
Bristol-Myers Squibb
Vanderbilt-Ingram Cancer Center